{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:59:56Z","timestamp":1753891196681,"version":"3.41.2"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The spread of the new SARS-CoV-2 is marked by a short timeline. In this scenario, explaining or excluding the possible transmission routes is mandatory to contain and manage the spread of the disease in the community. In the recent pandemic, it is still unclear how coronavirus can end up in ocular fluids. Nevertheless, eye redness and irritation in COVID-19 patients have been reported, suggesting that a possible ocular manifestation of SARS-CoV-2 infection may be conjunctivitis. On the basis of epidemiological data provided by previous SARS-Cove infection, numerous theories have been proposed: (1) conjunctiva as the site of direct inoculation by infected droplets; (2) the nasolacrimal duct as a migration route of the virus to the upper respiratory tract, or (3) haematogenic infection of the tear gland. The demand for further investigations to verify ocular involvement in COVID-19 infection came out from the results of recent meta-analysis studies, so the eye cannot be completely excluded as a transmission route of the infection. Thus, healthcare personnel and all the people that enter in contact with infected or suspected patients must always use the prescribed protective equipment.<\/jats:p>","DOI":"10.3389\/fmed.2020.620412","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T06:05:46Z","timestamp":1609826746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Do Ocular Fluids Represent a Transmission Route of SARS-CoV-2 Infection?"],"prefix":"10.3389","volume":"7","author":[{"given":"Giulio","family":"Petronio Petronio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00011-020-01366-6","article-title":"The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?","volume":"69","author":"Bellinvia","year":"2020","journal-title":"Inflamm Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B3","unstructured":"COVID-19 Italy Situation2020"},{"key":"B4","unstructured":"COVID-19 Integrated Surveillance Data in Italy2020"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"23","author":"Onder","year":"2020","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2003121","DOI":"10.2807\/1560-7917.ES.2020.25.10.2003121","article-title":"Updated rapid risk assessment from ECDC on the novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU\/EEA and the UK","volume":"25","author":"Team","year":"2020","journal-title":"Euro Surveill."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.26355\/eurrev_202002_20379","article-title":"Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV","volume":"24","author":"Meo","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41575-020-0295-7","article-title":"COVID-19: faecal\u2013oral transmission?","volume":"17","author":"Hindson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3906\/sag-2004-172","article-title":"Epidemiology of COVID-19","volume":"50","author":"Bulut","year":"2020","journal-title":"Turkish J Med Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1097\/SLA.0000000000004030","article-title":"SARS-CoV-2 is present in peritoneal fluid in COVID-19 patients","volume":"272","author":"Coccolini","year":"2020","journal-title":"Ann Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/ced.14274","article-title":"Observations about sexual and other routes of SARS-CoV-2 (COVID-19) transmission and its prevention","volume":"45","author":"Tatu","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ophtha.2020.03.026","article-title":"Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients","volume":"127","author":"Jun","year":"2020","journal-title":"Ophthalmology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2020.1738501","article-title":"Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals","volume":"28","author":"Seah","year":"2020","journal-title":"Ocul Immunol Inflamm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int J Oral Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/MMBR.00058-12","article-title":"Ocular tropism of respiratory viruses","volume":"77","author":"Belser","year":"2013","journal-title":"Microbiol Mol Biol Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"crossref","unstructured":"SarmaP\n            KaurH\n            KaurH\n            BhattacharyyaJ\n            PrajapatM\n            ShekharN\n          Ocular Manifestations and Tear or Conjunctival Swab PCR Positivity for 2019-nCoV in Patients With COVID-19: A Systematic Review and Meta-Analysis2020","DOI":"10.2139\/ssrn.3566161"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/jmv.25938","article-title":"Conjunctivitis and COVID-19: a meta-analysis","volume":"92","author":"Loffredo","year":"2020","journal-title":"J Med Virol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1055\/a-1164-9381","article-title":"COVID-19: ophthalmological aspects of the SARS-CoV 2 global pandemic","volume":"237","author":"Siedlecki","year":"2020","journal-title":"Klin Monbl Augenheilkd."},{"key":"B21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5935\/0004-2749.20200067","article-title":"COVID-19 and the eye: how much do we really know? A best evidence review","volume":"83","author":"Emparan","year":"2020","journal-title":"Arq Bras Oftalmol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.20344\/amp.14118","article-title":"SARS-COV-2 in ophthalmology: current evidence and standards for clinical practice","volume":"33","author":"Torres-Costa","year":"2020","journal-title":"Acta M\u00e9d Port."},{"key":"B23","first-page":"185","article-title":"Natural defense mechanisms of the ocular surface","volume-title":"Ocular Infection and Immunity","author":"Mannis","year":"1996"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e23710","DOI":"10.1371\/journal.pone.0023710","article-title":"Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans","volume":"6","author":"Lang","year":"2011","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/sj.eye.6700617","article-title":"Immune defense at the ocular surface","volume":"17","author":"Akpek","year":"2003","journal-title":"Eye."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e649","DOI":"10.1111\/aos.14445","article-title":"Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19","volume":"98","author":"Hong","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.preteyeres.2004.04.003","article-title":"Changes in the tear film and ocular surface from dry eye syndrome","volume":"23","author":"Johnson","year":"2004","journal-title":"Progr Retinal Eye Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"110082","DOI":"10.1016\/j.mehy.2020.110082","article-title":"Natural protection of ocular surface from viral infections\u2013a hypothesis","volume":"143","author":"Zimmerman","year":"2020","journal-title":"Med Hypoth."},{"key":"B29","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.7326\/M20-1176","article-title":"SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection","volume":"17","author":"Colavita","year":"2020","journal-title":"Ann Intern Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0161-6420(03)00262-8","article-title":"Prevalence of dry eye among an elderly Chinese population in Taiwan","volume":"110","author":"Pei-Yu","year":"2003","journal-title":"Ophthalmology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jaapos.2020.05.002","article-title":"Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report","volume":"24","author":"Valente","year":"2020","journal-title":"J Am Assoc Pediatric Ophthalmol Strabismus."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.4103\/ijo.IJO_1287_20","article-title":"Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients","volume":"68","author":"Kumar","year":"2020","journal-title":"Indian J Ophthalmol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/s41433-020-0965-2","article-title":"Detection of severe acute respiratory syndrome coronavirus-2 in the tears of patients with coronavirus disease 2019","volume":"34","author":"Karimi","year":"2020","journal-title":"Eye."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26219","article-title":"Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?","author":"G\u00fcemes-Villahoz","year":"2020","journal-title":"J. Med. Virol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10792-020-01575-2","article-title":"Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye","author":"Al-Sharif","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fpubh.2020.00155","article-title":"Role of the eye in transmitting human coronavirus: what we know and what we do not know","volume":"8","author":"Sun","year":"2020","journal-title":"Front Public Health."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00347-020-01160-z","article-title":"Kann SARS-CoV-2 das auge infizieren?\u2013ein \u00fcberblick \u00fcber den Rezeptorstatus in okularem Gewebe","volume":"24","author":"Schnichels","year":"2020","journal-title":"Ophthalmologe."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/jmv.25753","article-title":"Is novel coronavirus disease (COVID-19) transmitted through conjunctiva?","volume":"92","author":"Peng","year":"2020","journal-title":"J Med Virol"},{"volume-title":"Linee di Indirizzo Assistenziali Del Paziente Critico Affetto da Covid-19","year":"2020","author":"Salute","key":"B39"},{"key":"B40","doi-asserted-by":"publisher","first-page":"9036847","DOI":"10.1155\/2020\/9036847","article-title":"The importance of telemedicine during COVID-19 pandemic: a focus on diabetic retinopathy","volume":"2020","author":"Galiero","year":"2020","journal-title":"J Diabetes Res."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.620412\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T06:05:56Z","timestamp":1609826756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.620412\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":40,"alternative-id":["10.3389\/fmed.2020.620412"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.620412","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"article-number":"620412"}}